Chronic Pain Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 20+ Companies Working in the Domain
30 janv. 2025 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Chronic Pain Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 20+ Companies Working in the Domain ...
BRAF Inhibitors Market to Register Incremental Growth During the Study Period (2020–2034) | DelveInsight
29 janv. 2025 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, Jan. 29, 2025 (GLOBE NEWSWIRE) -- BRAF Inhibitors Market to Register Incremental Growth During the Study Period (2020–2034) | DelveInsight The BRAF Inhibitors market is expected to...
Pulmonary Fibrosis Clinical Trial Pipeline Appears Robust With 110+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
28 janv. 2025 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Pulmonary Fibrosis Clinical Trial Pipeline Appears Robust With 110+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight ...
Glioblastoma Market, an Area With High Trial Failure And Unmet Need is Expected to Witness Significant Growth Owing to Increased Usage of Bevacizumab, Temozolimide, Optune Gio Along with Emergence of New Class of Therapies | DelveInsight
27 janv. 2025 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Glioblastoma Market, an Area With High Trial Failure And Unmet Need is Expected to Witness Significant Growth Owing to Increased Usage of...
Phage Therapies Clinical Trial Pipeline Shows Potential with Active Contributions from 20+ Key Companies | DelveInsight
23 janv. 2025 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Phage Therapies Clinical Trial Pipeline Shows Potential with Active Contributions from 20+ Key Companies | DelveInsight The phage therapy market is...
5-HT2 Agonist Clinical Trial Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
22 janv. 2025 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, Jan. 22, 2025 (GLOBE NEWSWIRE) -- 5-HT2 Agonist Clinical Trial Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight ...
Bronchiectasis Market to Show Positive Growth at a CAGR of 13.7% by 2034 | DelveInsight
21 janv. 2025 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, Jan. 21, 2025 (GLOBE NEWSWIRE) -- Bronchiectasis Market to Show Positive Growth at a CAGR of 13.7% by 2034 | DelveInsight The bronchiectasis market is expected to experience steady...
Advancements in Ocular Hypertension Clinical Trial Pipeline as 60+ Companies Pave the Way for Future Solutions | DelveInsight
20 janv. 2025 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, Jan. 20, 2025 (GLOBE NEWSWIRE) -- Advancements in Ocular Hypertension Clinical Trial Pipeline as 60+ Companies Pave the Way for Future Solutions | DelveInsight The ocular...
Global Exosome Diagnostics Market is Projected to Boom with an Enormous CAGR of ~47% by 2032 | DelveInsight
16 janv. 2025 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, Jan. 16, 2025 (GLOBE NEWSWIRE) -- Global Exosome Diagnostics Market is Projected to Boom with an Enormous CAGR of ~47% by 2032 | DelveInsight The rising incidence of cancer is...
Liver Cirrhosis Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 30+ Companies Working in the Domain
15 janv. 2025 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, Jan. 15, 2025 (GLOBE NEWSWIRE) -- Liver Cirrhosis Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 30+ Companies Working in the...